Report Finds High Costs For Pay-For-Delay Drugs
Reverse payment patent settlements have left U.S. consumers paying on average 10 times more for brand-name versions of key drugs used to treat everything from breast cancer to high cholesterol while...To view the full article, register now.
Already a subscriber? Click here to view full article